Stock listing

ASX:PCK PainChek Ltd Share Price

Follow PainChek Ltd into a list and get an email when it puts out news.

Share price · ASX:PCK

$0.064 AUD -0.003 (-4.5%)

Close on Nov 20, 2026

Past year -84.0% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.060 – $0.064 AUDNov 20, 2026
Volume
21,526 sharesNov 20, 2026
Market cap
$13.39M AUDAt the close on Nov 20, 2026 · price × 209.2M shares outstanding
52-week range
$0.060 – $0.400 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$13,165 AUDMedian day 72,866 shares · 4 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
PainChek Ltd logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:PCK · AUD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.064-0.003-4.5%$0.060$0.064$0.06021,526
$0.067-0.001-1.5%$0.067$0.067$0.065163,533
$0.0680.0000.0%$0.068$0.068$0.06820,888
$0.068-0.001-1.4%$0.070$0.071$0.068202,366
$0.069-0.001-1.4%$0.069$0.069$0.06925,604
$0.070-0.003-4.1%$0.069$0.070$0.06968,517
$0.073+0.003+4.3%$0.070$0.073$0.069181,200
$0.0700.0000.0%$0.070$0.070$0.0700
$0.0700.0000.0%$0.070$0.070$0.0700
$0.0700.0000.0%$0.070$0.070$0.0700
$0.070+0.002+2.9%$0.068$0.070$0.06883,147
$0.068-0.007-9.3%$0.074$0.074$0.06731,839
$0.075+0.008+11.9%$0.068$0.075$0.06821,558
$0.067-0.011-14.1%$0.070$0.070$0.06730,575
$0.078+0.008+11.4%$0.070$0.078$0.07054,717
$0.070-0.004-5.4%$0.074$0.074$0.070239,770
$0.074+0.004+5.7%$0.082$0.082$0.074152,586
$0.070-0.003-4.1%$0.070$0.070$0.065320,392
$0.073-0.005-6.4%$0.078$0.080$0.070151,263
$0.078-0.010-11.4%$0.088$0.088$0.0781,049,576
$0.088-0.001-1.1%$0.088$0.088$0.0886,420
$0.089-0.001-1.1%$0.092$0.092$0.089121,976
$0.090+0.002+2.3%$0.090$0.090$0.09032,222
$0.088-0.005-5.4%$0.092$0.092$0.08839,319
$0.093+0.001+1.1%$0.095$0.097$0.089241,443
$0.092+0.002+2.2%$0.097$0.097$0.089353,884
$0.090+0.004+4.7%$0.095$0.095$0.090231,698
$0.086-0.013-13.1%$0.100$0.140$0.0861,629,346
$0.099+0.004+4.2%$0.095$0.099$0.09519,435
$0.095-0.001-1.0%$0.095$0.095$0.095218
$0.0960.0000.0%$0.096$0.096$0.094185,273
$0.0960.0000.0%$0.096$0.096$0.094143,156
$0.096-0.001-0.5%$0.096$0.096$0.09615,924
$0.0970.0000.0%$0.097$0.097$0.0970
$0.097+0.002+1.6%$0.095$0.097$0.095131,429
$0.095-0.001-1.0%$0.098$0.099$0.09576,461
$0.0960.0000.0%$0.096$0.096$0.09677,829
$0.096-0.001-1.0%$0.096$0.096$0.0961,000
$0.0970.0000.0%$0.097$0.097$0.09734,158
$0.0970.0000.0%$0.097$0.097$0.0977,500
$0.097-0.008-7.6%$0.105$0.105$0.09621,139
$0.105-0.005-4.5%$0.105$0.105$0.10575,540
$0.1100.0000.0%$0.110$0.110$0.11087,672
$0.1100.0000.0%$0.110$0.110$0.1102,588
$0.110-0.005-4.3%$0.115$0.115$0.11034,108
$0.1150.0000.0%$0.115$0.115$0.115398
$0.1150.0000.0%$0.115$0.115$0.1155,000
$0.1150.0000.0%$0.115$0.115$0.115173,266
$0.1150.0000.0%$0.115$0.120$0.11546,231
$0.115-0.010-8.0%$0.115$0.125$0.115100,388
$0.1250.0000.0%$0.130$0.130$0.12577,936
$0.125+0.010+8.7%$0.120$0.130$0.120190,874
$0.115+0.005+4.5%$0.110$0.115$0.110100,684
$0.1100.0000.0%$0.110$0.110$0.10570,191
$0.110+0.005+4.8%$0.105$0.110$0.10595,255
$0.105+0.009+9.4%$0.100$0.105$0.10094,055
$0.096-0.002-2.0%$0.096$0.125$0.0961,478,284
$0.098+0.003+3.2%$0.095$0.098$0.09528,019
$0.095+0.001+1.1%$0.095$0.095$0.09568,126
$0.0940.0000.0%$0.094$0.094$0.0943,745
$0.0940.0000.0%$0.094$0.094$0.094251
$0.094+0.001+1.1%$0.093$0.095$0.092129,443
$0.0930.0000.0%$0.093$0.093$0.09352,439
$0.093-0.005-5.1%$0.097$0.098$0.092372,063
$0.098-0.001-1.0%$0.100$0.100$0.09885,480
$0.099-0.001-1.0%$0.097$0.100$0.097162,005

Splits

2 splits since 2016 · ASX:PCK · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
4-for-7Consolidation
Ticker
ASX:PCK
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
ASX
Currency
AUD

What changed lately

Latest news

Results of Meeting

Nov 4, 2026

Closed $0.07 (+2.9%) on Nov 5, 2026

PCK AGM watching the live feed

Nov 1, 2026

Closed $0.067 (-14.1%) on Nov 2, 2026

Final Director's Interest Notice

Oct 30, 2026

Closed $0.078 (+11.4%) on Oct 30, 2026

Change of Director's Interest Notice x3

Sep 30, 2026

Closed $0.096 (0.0%) on Sep 30, 2026

All PainChek Ltd news

PainChek Ltd on 6ix

Sector
Health care
Industry
Health care services
News releases
34 in the last 12 months · 156 in all · newest Nov 4, 2026 · oldest 2016
Decks
30 decks · latest Nov 4, 2026

Cash and shares

Oct 2025 deck · PainChek — Investor Presentation (October 2025)

Cash
A$6.3 million

The slide these figures come from

Valuation

EV/sales 3.1× against a median of 5.4×: 5th lowest of 11 Health care services companies shown. Statements: Year to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$11.65M AUD
P/E
Loss
EV/sales
3.1×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
70.5%
Operating margin
−265.0%
Net margin
−238.8%
Debt to equity
Negative equity
Beta
No index for this market yet

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
PainChek Ltd · ASX:PCKUS$8.86MUS$7.71Mn/a3.1×n/an/a−238.8%n/an/a
Concord Medical Services Holdings Ltd. · NYSE:CCMUS$9.99MUS$510.9Mn/a7.4×n/an/a−20.2%n/a0.49
Vidavo SA · ATHEX:VIDAVOUS$9.78MUS$8.25M15.0×3.5×9.2×4.1×27.4%0.0×n/a
AIML Innovations Inc · CSE:AIMLUS$9.68MUS$11.23Mn/a368×n/an/an/an/a0.33
UCrest Bhd · MYX:UCRESTUS$9.05MUS$6.78M138×2.0×34.7×0.9×1.9%0.0×n/a
HeartSciences Inc. · NASDAQ:HSCSUS$8.99MUS$8.96Mn/a1,984×n/an/an/an/a1.23
Good Fellow Healthcare Holdings Limited · HKEX:8143US$8.53MUS$6.81Mn/a2.7×n/a8.2×−62.4%0.1×n/a
KDA Group Inc. · TSXV:KDAUS$8.51MUS$8.34Mn/a28.6×n/a2.0×n/a0.0×-0.76
InteliCare Holdings Limited · ASX:ICRUS$8.05MUS$8.25Mn/a13.0×n/an/a−234.6%n/an/a
SEI Medical Public Co., Ltd. · SET:SEIUS$7.91MUS$4.28M8.7×0.3×2.5×0.9×7.5%0.0×n/a
Medicskin Holdings Ltd. · HKEX:8307US$7.85MUS$6.33M65.7×1.0×6.6×11.8×2.0%3.4×n/a
Median of the othersUS$8.76MUS$8.25M40.4×5.4×7.9×3.1×1.9%0.0×0.41

Team and board

Officers

OfficerRole
Karen HolzbergerChief Executive Officer
Iain McAdamChief Financial Officer
Andy HogganChief Operating Officer
Natalie ClimoCompany Secretary
Christelle UcinekHead of Business Development, ANZ
Jeff HughesChief Scientific Officer
Joseph FarmboroughChief Technology and Innovation Officer
Sasha GrantHead of Growth, PainChek Infant App
Tandeep GillGeneral Manager & Head of Business Development, UK&I

Board

DirectorRole
Lil BianchiNon-Executive Director and Non-Executive Chair of the Board
Adam DaveyNon-Executive Director
Cynthia PayneNon-Executive Director
John MurrayNon-Executive Director

Events

QuarterResultsShare move
Q4 2025Aug 28, 20250.0%
Q2 2025Feb 27, 2025−9.1%
Q2 2023Feb 28, 2023 · After close−3.6%
Q4 2022Aug 30, 2022 · After close0.0%
Q2 2022Feb 27, 2022 · After close−2.4%
Q4 2021Aug 30, 2021 · After close−4.0%
Q2 2021Feb 25, 2021 · Before open−3.7%

Open Events

Decks

DeckKindSlidesDate
Shareholder Meeting (November 2026)Shareholder meeting14 slidesNov 4, 2026
Shareholder Meeting (November 2025)Shareholder meeting28 slidesNov 26, 2025
Investor Presentation (October 2025)Investor deck27 slidesOct 31, 2025
Investor Presentation (July 2025)Investor deck34 slidesJul 28, 2025
Earnings Presentation (May 2025)Earnings32 slidesMay 1, 2025
Q1 FY25 Earnings PresentationEarnings32 slidesOct 30, 2024
Investor Presentation (July 2024)Investor deck41 slidesJul 30, 2024
Investor Presentation (January 2024)Investor deck35 slidesJan 30, 2024
Shareholder Meeting (November 2023)Shareholder meeting23 slidesNov 22, 2023
Investor Presentation (October 2023)Investor deck23 slidesOct 31, 2023
All 30 decks
DeckKindSlidesDate
Investor Presentation (September 2023)Investor deck42 slidesSep 14, 2023
Corporate Update (July 2023)Corporate update32 slidesJul 27, 2023
Investor Presentation (May 2023)Investor deck38 slidesMay 2, 2023
Investor Presentation (January 2023)Investor deck26 slidesJan 31, 2023
Shareholder Meeting (November 2022)Shareholder meeting24 slidesNov 23, 2022
Investor Presentation (August 2022)Investor deck31 slidesAugust 2022
Investor Presentation (June 2022)Investor deck34 slidesJun 24, 2022
Corporate Update (May 2022)Corporate update24 slidesMay 3, 2022
Corporate Update (January 2022)Corporate update27 slidesJan 28, 2022
Webinar: Pain and Dementia (October 2021)Conference21 slidesOct 27, 2021
Corporate Update (January 2021)Corporate update22 slidesJan 22, 2021
Shareholder Meeting (November 2020)Shareholder meeting16 slidesNov 26, 2020
Conference Presentation (August 2020)Conference26 slidesAug 3, 2020
NWR Communications Virtual Health Conference (May 2020)Conference25 slidesMay 1, 2020
Investor Presentation (November 2019)Investor deck19 slidesNov 28, 2019
Shareholder Meeting (November 2019)Shareholder meeting13 slidesNov 20, 2019
Investor Presentation (March 2019)Investor deck22 slidesMar 12, 2019
Investor Presentation (October 2018)Investor deck31 slidesOct 16, 2018
Investor Presentation (September 2018)Investor deck29 slidesSep 11, 2018
Investor Presentation (May 2018)Investor deck29 slidesMay 17, 2018

Open Decks

Financials

Annual, in AUD

Income statement

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue3.74M3.36M2.67M1.95M978.6K214.8K248.2K215.5K50.6K31.1K
Cost of revenue1.10M2.36M1.95M1.24M1.24M639.0K265.2K265.2K1.71M150
Gross profit2.64M997.7K726.7K712.5K-258.8K-424.2K-17.0K215.5K-1.66M31.0K
Research and development3.32M3.78M4.57M3.82M2.35M2.65M2.27M1.89M1.70M821.4K
Selling, general and administrative8.63M3.22M3.40M3.54M3.05M3.80M10.8M1.40M1.34M3.01M
Operating income-9.92M-9.11M-9.51M-8.76M-7.59M-8.97M-15.0M-3.26M-4.81M-4.01M
Depreciation and amortization13.2K18.2K25.6K17.0K14.4K59.5K43.0K3.17K4.03K150
EBITDA-9.90M-9.09M-9.49M-8.75M-7.57M-8.91M-15.0M-3.26M-4.81M-4.00M
Interest expense196.6K15.6K00000
Income before tax-10.1M-7.67M-8.31M-8.62M-6.81M-7.12M-13.2M-3.26M-4.81M-8.47M
Income tax-1.12M-1.41M-1.21M-1.05M-1.09M-1.06M-798.8K-745.3K0-31.3K
Net income-8.94M-7.67M-8.31M-7.57M-5.72M-6.06M-12.4M-3.26M-4.81M-8.47M
Earnings per share, basic-0.04-0.04-0.06-0.01-0.05-0.01-0.01-0.00-0.01-0.16

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents5.99M1.62M3.56M2.51M6.14M11.4M6.12M4.56M3.61M2.63M
Receivables1.53M446.0K521.7K201.7K436.8K315.8K69.1K161.3K56.1K45.0K
Inventory-166.5K148.0K57.1K8.51K-161.3K-56.1K
Current assets7.61M2.13M4.15M2.77M6.63M11.8M6.20M4.73M3.67M2.69M
Property, plant and equipment19.5K29.4K22.8K26.2K18.5K18.0K15.7K4.38K2.54K
Total assets7.63M2.15M4.18M2.80M6.65M11.8M6.22M4.75M3.67M2.69M
Accounts payable833.0K801.7K842.9K498.6K275.5K325.1K231.2K202.1K287.0K104.5K
Current liabilities7.67M3.26M2.89M2.13M1.83M3.57M2.09M628.4K447.9K207.2K
Total debt4.25M
Total liabilities9.06M3.26M2.89M2.13M1.83M3.57M2.09M628.4K447.9K207.2K
Shareholders' equity-1.43M-1.11M1.29M668.1K4.82M8.24M4.13M4.12M3.22M2.48M
Shares outstanding206.1M173.7M148.1M1.29B112.8M1.12B992.3M841.1M800.9M52.1M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-9.24M-6.75M-7.13M-6.32M-7.00M-4.12M-1.89M-3.07M-2.91M-1.58M
Capital spending-14.9K-12.2K-34.3K-13.6K-22.0K-60.0K-45.6K-14.5K-5.87K-5.87K
Free cash flow-9.25M-6.77M-7.16M-6.34M-7.02M-4.18M-1.93M-3.09M-2.92M-1.58M
Cash from investing-14.9K-12.2K-34.3K-12.4K-22.0K-60.0K-45.6K-14.5K-5.87K18.3K
Cash from financing13.6M4.82M8.21M2.70M1.75M9.48M3.51M4.05M3.90M4.11M
Dividends paid-8.23M
Share buybacks5.12M-459.9K-126.6K-198.0K-522.8K-55.7K-168.8K4.12M4.73M
Change in cash4.38M-1.94M1.05M-3.63M-5.28M5.30M1.56M956.4K976.1K2.55M

Open Financials

Filings

FilingDateTypeFiled with
Results of MeetingNov 4, 2026Meeting outcomeASX
Chair's Address to Shareholders and CEO presentationNov 3, 2026Meeting outcomeASX
PCK AGM watching the live feedNov 1, 2026Meeting noticeASX
Final Director's Interest NoticeOct 30, 2026Ownership change noticeASX
Quarterly Activities/Appendix 4C Cash Flow ReportOct 27, 2026Quarterly reportASX
Quarterly Activities/Appendix 4C Cash Flow ReportOct 27, 2026Quarterly reportASX
PainChek wins 1,800-licence UK contract with HallmarkOct 26, 2026Operations updateASX
John Murray retires as PainChek non-executive directorOct 25, 2026Management or board changeASX
Notification regarding unquoted securities - PCKOct 12, 2026Other filingsASX
PainChek expands Sabra contracts to 23 US communitiesOct 12, 2026Operations updateASX
All 156 filings
FilingDateTypeFiled with
Change of Director's Interest Notice x3Sep 30, 2026Ownership change noticeASX
Application for quotation of securities - PCKSep 30, 2026FinancingASX
Notice of Annual General Meeting/Proxy FormSep 29, 2026Meeting noticeASX
Corporate Governance Statement and Appendix 4G 2026Sep 22, 2026Other filingsASX
Annual Report to shareholdersSep 22, 2026Annual reportASX
Final Director's Interest NoticeSep 7, 2026Ownership change noticeASX
Investor Webinar InviteSep 2, 2026Other filingsASX
Resignation of Non-Executive DirectorSep 2, 2026Management or board changeASX
Appendix 4E and Financial ReportAug 28, 2026ResultsASX
PainChek Investor WebinarAug 6, 2026Other filingsASX
Update - Notification regarding unquoted securities - PCKAug 5, 2026Other filingsASX
Change of Director's Interest Notice x 4Aug 5, 2026Ownership change noticeASX
Quarterly Activities/Appendix 4C Cash Flow ReportJul 28, 2026Quarterly reportASX
PainChek receives $1.123 million R&D tax incentive refundJul 21, 2026ResultsASX
US MedTech leader Karen Holzberger appointed CEOJul 19, 2026Other filingsASX
CEO TransitionJul 6, 2026Other filingsASX
PainChek secures A$5.5m note to fund US expansionMay 21, 2026FinancingASX
Landmark Sabra North America deployment targeting 20k bedsApr 13, 2026Operations updateASX
PainChek reports material sales momentum in UKMar 25, 2026Operations updateASX
Half Yearly Report and AccountsFeb 27, 2026Interim reportASX
Quarterly Activities/Appendix 4C Cash Flow ReportJan 29, 2026Quarterly reportASX
PainChek Business UpdateJan 29, 2026Operations updateASX
PainChek gains access to RTM reimbursement in USAJan 28, 2026Operations updateASX
AGM PresentationNov 25, 2025Meeting noticeASX
Investor PresentationOct 30, 2025Other filingsASX
Notice of Annual General Meeting/Proxy FormOct 24, 2025Meeting noticeASX
Key hire to drive Infant App in $15Bn addressable marketOct 16, 2025Management or board changeASX
Response to ASX Aware LetterOct 16, 2025Explanation requestASX
PainChek Secures First US Customer Following FDA ClearanceOct 12, 2025Operations updateASX
PainChek FDA Cleared to Commence Sales in US$100M US MarketOct 8, 2025Operations updateASX
Trading HaltOct 6, 2025Trading halt or suspensionASX
Compelling Clinical and Economic Results in Scottish PilotSep 16, 2025Operations updateASX
Preliminary Final ReportAug 28, 2025ResultsASX
Strongly Supported A$7.5m Placement to Drive Int. GrowthJul 28, 2025FinancingASX
Final US FDA De Novo Clearance Submission CompletedJul 20, 2025Operations updateASX
PainChek Reports Strong Quarterly Sales GrowthJul 2, 2025Quarterly reportASX
PainChek has productive final FDA De Novo clearance meetingJun 4, 2025Operations updateASX
PainChek partners with Eldermark to expand US market reachMay 26, 2025Other filingsASX
R&D Tax Refund, FDA Review of Adult App & Infant App LaunchApr 15, 2025Other filingsASX
PainChek completes Entitlement Offer raising AUD $5.1 mDec 16, 2024FinancingASX
PainChek Implementations, Market and International ExpansionDec 10, 2024Operations updateASX
ProspectusNov 24, 2024Offer documentASX
Underwritten Entitlement Offer to raise AUD $5.1millionNov 24, 2024FinancingASX
PCK submits application for Adult App FDA De Novo clearanceNov 19, 2024Other filingsASX
PCK expands market reach with BESTMED reseller agreementNov 12, 2024Operations updateASX
Positive study results pave way for PainChek FDA submissionOct 28, 2024Other filingsASX
PainChek Adult app FDA De Novo submission updateOct 1, 2024Operations updateASX
PainChek receives European patent for pain assessment techMay 27, 2024Other filingsASX
PainChek receives $1,210,000 R&D Tax Incentive RefundApr 22, 2024Other filingsASX
PainChek UK partnership with Nourish CareMar 13, 2024Operations updateASX
PainChek completes A$5m capital raiseMar 13, 2024FinancingASX
PainChek Share Purchase Plan oversubscribedMar 6, 2024FinancingASX
Underwritten Share Purchase Plan to raise AUD $2.5 millionFeb 13, 2024FinancingASX
Notice of Acceptance for European PatentNov 20, 2023Other filingsASX
Quarterly Update and Appendix 4COct 30, 2023Quarterly reportASX
Response to ASX Price QueryOct 9, 2023Explanation requestASX
PainChek A$3.55m PlacementSep 14, 2023FinancingASX
US nursing home study to pave way for FDA De Novo clearanceAug 24, 2023Other filingsASX
PainChek receives $1.049m R&D Tax Incentive RefundJul 24, 2023Other filingsASX
Ethos Laboratories Distribution AgreementJun 15, 2023Other filingsASX
AGM CEO PresentationNov 22, 2022Other filingsASX
Response to ASX QuerySep 30, 2022Explanation requestASX
PCK expands activities to Japan with JETRO business connectSep 25, 2022Other filingsASX
Financial Statements 30 June 2022 & Appendix 4EAug 31, 2022ResultsASX
Results of Non-Renounceable Entitlement OfferJul 29, 2022FinancingASX
PCK receives funding for 12 month pilot in Welsh care homesJul 26, 2022Other filingsASX
PCK to receive Govt funding for childrens disability appJul 5, 2022Other filingsASX
Offer BookletJul 4, 2022Offer documentASX
Equity Raising & Results of PlacementJun 24, 2022FinancingASX
Quarterly Investor Update PresentationMay 2, 2022Other filingsASX
Summerset Holdings Ltd rolls out PainChek in NZMar 27, 2022Other filingsASX
Appendix 4D and Half Year ReportFeb 27, 2022Interim reportASX
Quarterly Update Investor PresentationJan 28, 2022Other filingsASX
Response to ASX Price and Volume QueryNov 29, 2021Explanation requestASX
September Quarterly UpdateOct 21, 2021Other filingsASX
Appendix 4C Cash Flow ReportOct 21, 2021Quarterly reportASX
Quarterly Update June 2021Jul 28, 2021Other filingsASX
Appendix 4CJul 28, 2021Quarterly reportASX
PainChek to receive $1.25M milestone payment from DoHJun 27, 2021Other filingsASX
PainChek Infant Achieves International Regulatory ClearancesMay 19, 2021Other filingsASX
Appendix 4C - quarterlyApr 28, 2021Quarterly reportASX
March 2021 Quarterly UpdateApr 28, 2021Other filingsASX
PainChek receives CE Mark & TGA clearance for Universal AppMar 16, 2021Other filingsASX
S&P DJI Announces March 2021 Quarterly RebalanceMar 12, 2021Other filingsASX
Appendix 4D & Financial StatementsFeb 25, 2021Interim reportASX
Presentation - December 2020 Quarter UpdateJan 21, 2021Other filingsASX
December 2020 Quarterly UpdateJan 21, 2021Other filingsASX
PainChek receives regulatory clearance from Health CanadaNov 18, 2020Other filingsASX
New Zealand expansion through Medi-map partnershipNov 1, 2020Other filingsASX
September 2020 Quarterly UpdateOct 30, 2020Other filingsASX
AlayaCare to partner PCK in Canadian Home Care MarketOct 27, 2020Other filingsASX
Partnership with Nulsen Group for Disability Pain ManagementOct 22, 2020Other filingsASX
Partnership with Ramsay & ECU for Hospital Pain ManagementOct 1, 2020Other filingsASX
Proposed issue of Securities - PCKAug 10, 2020FinancingASX
June 2020 Quarterly UpdateJul 27, 2020Other filingsASX
S&P DJI Announces June 2020 Quarterly RebalanceJun 11, 2020Other filingsASX
50% growth in beds, clients & facilities in March quarterApr 29, 2020Other filingsASX
25,000 Govt Bed Milestone Achieved, Triggers $1.25m PaymentMar 18, 2020Other filingsASX
PainChek receives $798,000 R&D Tax IncentiveFeb 2, 2020Other filingsASX
Update on PainChek Business PerformanceDec 22, 2019Other filingsASX
DACS Grant Funding Contract for National Trial SignedDec 3, 2019Other filingsASX
Quarterly UpdateOct 30, 2019Other filingsASX
Singapore Regulatory Clearance Received. Allium AgreementAug 5, 2019Other filingsASX
PainChek Partners with MCRI for Infant App PainFaces StudyJul 1, 2019Other filingsASX
$4.15M Placement to Fast-Track International ExpansionJun 18, 2019FinancingASX
International Market Milestone Achieved with UK DistributionMay 26, 2019Other filingsASX
Morrison Govt $5M Grant for PainChek Trial in Aged CareApr 29, 2019Other filingsASX
Pause in TradingApr 26, 2019Trading halt or suspensionASX
Churches of Christ License PCK for 1,000 RAC BedsApr 8, 2019Other filingsASX
Agreement with Leecare SolutionsOct 2, 2018Other filingsASX
Allity Aged Care partners with PainChekSep 9, 2018Other filingsASX
Investor UpdateJul 30, 2018Other filingsASX
National roll out with DSA follows successful pilotJun 13, 2018Other filingsASX
New publication confirms accuracy of PainChek(R)Jun 6, 2018Other filingsASX
PainChek receives FDA regulatory guidanceMay 9, 2018GuidanceASX
Agreement signed with leading software system providerMar 27, 2018Other filingsASX
Half Year Report and Financial StatementsFeb 23, 2018Interim reportASX
PainChek App Android version now in beta testingJan 29, 2018Other filingsASX
New Peer reviewed published studyJan 28, 2018Other filingsASX
2nd peer-review confirms excellent performance of PainChekDec 12, 2017Other filingsASX
ePAT and PainChek continue to achieve commercial milestonesNov 8, 2017Other filingsASX
Placement to raise $3.75 millionSep 17, 2017FinancingASX
Core strategic agreement with Dementia Support AustraliaSep 6, 2017Other filingsASX
ePAT Clinical Study Published in Alzheimers Disease JournalAug 15, 2017Other filingsASX
nViso agrees perpetual global license, takes strategic stakeJul 24, 2017Other filingsASX
ePAT Pain Assessment App Secures Regulatory ClearanceJul 18, 2017Other filingsASX
New Study Validates Face Recognition App in Pain DetectionJul 3, 2017Other filingsASX
Launch of IBM Case StudyMar 15, 2017Other filingsASX
Second Quarter Report FY 2016/17Jan 30, 2017Other filingsASX
Market UpdateDec 14, 2016Other filingsASX
Quarterly Review and Appendix 4CDec 9, 2016Quarterly reportASX
Suspension from Official QuotationJul 18, 2016Trading halt or suspensionASX
MinQuest completes interim capital raisingJul 17, 2016FinancingASX
ePAT Signs MOU with UK Insurance Counter-Fraud GroupJun 15, 2016Other filingsASX
Update on ePAT for Infant AppsJun 1, 2016Other filingsASX
ePAT to commence test of new version of dementia AppMay 25, 2016Other filingsASX
ePAT validation tests successfulMay 18, 2016Other filingsASX
ePAT Acquisition Update - Completion of Due DiligenceMay 9, 2016Acquisition or disposalASX
Response to Price QueryMay 3, 2016Explanation requestASX
Quarterly Activities Report and Quarterly Cashflow ReportApr 29, 2016Quarterly reportASX
Reinstatement to Official QuotationApr 22, 2016Trading halt or suspensionASX
Completion of Interim Capital Raising and repayment of MagnaApr 21, 2016FinancingASX
MNQ to acquire ground-breaking pain management app developerApr 13, 2016Acquisition or disposalASX
Updated on bid for Wolverine zinc mineMar 30, 2016Other filingsASX
Marg Scoping Study confirms potentially viable projectFeb 11, 2016Other filingsASX
MinQuest agrees amended terms for Convertible Loan FacilityFeb 10, 2016Other filingsASX

Open Filings

Cap table

Built by 6ix from PainChek Ltd’s releases

Common shares
209,249,442
Fully diluted
209,249,442

Fully diluted

LineShares
Common shares209,249,442

Share count over time

CountShares
Nov 22, 2026209,249,442

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Adam DaveyNon-Executive Director · Since at least Sep 22, 2026
Andy HogganChief Operating Officer · Since at least Nov 4, 2026
Christelle UcinekHead of Business Development, ANZ · Since at least Nov 5, 2026
Cynthia PayneNon-Executive Director · Since at least Sep 22, 2026
Iain McAdamChief Financial Officer · Since at least Nov 5, 2026
Jeff HughesChief Scientific Officer · Since at least Nov 4, 2026
John MurrayNon-Executive Director · Since at least Oct 25, 2026
Joseph FarmboroughChief Technology and Innovation Officer · Since at least Nov 5, 2026
Karen HolzbergerChief Executive Officer · Since at least Nov 5, 2026
Lil BianchiNon-Executive Director and Non-Executive Chair of the Board · Since at least Sep 22, 2026
All 13 people
PersonSeat
Natalie ClimoCompany Secretary · Since at least Nov 5, 2026
Sasha GrantHead of Growth, PainChek Infant App · Since at least Nov 5, 2026
Tandeep GillGeneral Manager & Head of Business Development, UK&I · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about PainChek Ltd.